These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 25086683)

  • 1. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From G Protein-coupled Receptor Structure Resolution to Rational Drug Design.
    Jazayeri A; Dias JM; Marshall FH
    J Biol Chem; 2015 Aug; 290(32):19489-95. PubMed ID: 26100628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Allosteric Modulators of G Protein-coupled Receptors.
    Gentry PR; Sexton PM; Christopoulos A
    J Biol Chem; 2015 Aug; 290(32):19478-88. PubMed ID: 26100627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
    Cong X; Topin J; Golebiowski J
    Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of G-protein coupled receptor models in lead optimization.
    Tautermann CS
    Future Med Chem; 2011 Apr; 3(6):709-21. PubMed ID: 21554077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From heptahelical bundle to hits from the Haystack: structure-based virtual screening for GPCR ligands.
    Kooistra AJ; Roumen L; Leurs R; de Esch IJ; de Graaf C
    Methods Enzymol; 2013; 522():279-336. PubMed ID: 23374191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric inhibition of g-protein coupled receptor oligomerization: strategies and challenges for drug development.
    Hurevich M; Talhami A; Shalev DE; Gilon C
    Curr Top Med Chem; 2014; 14(15):1842-63. PubMed ID: 25175995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPCR crystal structures: Medicinal chemistry in the pocket.
    Shonberg J; Kling RC; Gmeiner P; Löber S
    Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
    Lee SM; Booe JM; Pioszak AA
    Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of GPCR structures in drug design.
    Congreve M; Langmead C; Marshall FH
    Adv Pharmacol; 2011; 62():1-36. PubMed ID: 21907905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
    Lu S; Zhang J
    J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fitting the complexity of GPCRs modulation into simple hypotheses of ligand design.
    Custodi C; Nuti R; Oprea TI; Macchiarulo A
    J Mol Graph Model; 2012 Sep; 38():70-81. PubMed ID: 23079642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thematic Minireview Series: New Directions in G Protein-coupled Receptor Pharmacology.
    Dohlman HG
    J Biol Chem; 2015 Aug; 290(32):19469-70. PubMed ID: 26126823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging Approaches to GPCR Ligand Screening for Drug Discovery.
    Kumari P; Ghosh E; Shukla AK
    Trends Mol Med; 2015 Nov; 21(11):687-701. PubMed ID: 26481827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are GPCRs still a source of new targets?
    Garland SL
    J Biomol Screen; 2013 Oct; 18(9):947-66. PubMed ID: 23945874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
    Wang CI; Lewis RJ
    Biochem Pharmacol; 2013 Jan; 85(2):153-62. PubMed ID: 22975406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
    Congreve M; Oswald C; Marshall FH
    Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging structural insights into biased GPCR signaling.
    Shukla AK; Singh G; Ghosh E
    Trends Biochem Sci; 2014 Dec; 39(12):594-602. PubMed ID: 25458114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR profiling: from hits to leads and from genotype to phenotype.
    Cvijic ME; Sum CS; Alt A; Zhang L
    Drug Discov Today Technol; 2015 Nov; 18():30-7. PubMed ID: 26723890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based drug design for G protein-coupled receptors.
    Congreve M; Dias JM; Marshall FH
    Prog Med Chem; 2014; 53():1-63. PubMed ID: 24418607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.